Late Biomarkers in Adult Survivors After Out-of-hospital Cardiac Arrest

NCT06587763 — Withdrawn, Region Skane

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT06587763
StatusWithdrawn - For logistical reasons, no patients were included before the main trial completed inclusion.
Study typeObservational
SponsorRegion Skane (Other); collaborators: Lund University, University of Helsinki
ConditionsCardiac Arrest, Out-Of-Hospital
Datesstart 2025-10-01 (estimated), primary completion 2028-12-31 (estimated), completion 2032-12-31 (estimated), first posted 2024-09-19, last updated 2026-08-21
Locations3 sites in Sweden

Related Papers Related Patents Related Grants Related Experts
All trials for Cardiac Arrest, Out-Of-Hospital

-Summary

Blood samples are collected at six months follow-up from adult survivors after out-of-hospital cardiac arrest. Patients will be informed about the study and if they consent to participation, venous blood will be drawn by authorised medical personnel. Plasma, serum and PAX-RNA will be collected (ca 15 ml in total), processed and frozen for analysis after trial completion.

Expand all sections  ·  Collapse all

+Detailed description

Blood samples are collected at six months follow-up from adult survivors after out-of-hospital cardiac arrest. Patients will be informed about the study and if they consent to participation, venous blood will be drawn by authorised medical personnel. Plasma, serum and PAX-RNA will be collected (ca 15 ml in total), processed and frozen for analysis after trial completion.

Samples will be analysed in batch for biomarkers of brain injury, inflammation etc.

Primary outcome is functional outcome (modified Rankin Scale 4-6) at six months after cardiac arrest.

Secondary outcomes are neurocognitive function according to the Montreal Cognitive Assessment (MoCA), Symbol Digits Modalities Test (SDMT).

+Outcome measures

Primary outcomes

  • Functional outcome [6 months]: Modified Rankin Scale 4-6

Secondary outcomes

  • Neurocognitive outcomes [6 months]: Montreal Cognitive Assessment
  • Neurocognitive outcomes [6 months]: Symbol Digit Modalities Test

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Survivors of out-of-cardiac arrest who participate in the extended follow-up study of the STEPCARE trial at selected sites only

Exclusion Criteria:

* Patients not participating in the extended follow-up at participating sites

+Locations (3)

FacilityCityCountryStatus
Helsingborgs HospitalHelsingborgSweden
Skåne university hospitalLundSweden
Skåne University HospitalMalmöSweden